| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | Rosiello Robert L. | EVP, Corp Dev & Strategy | Dec 05, 2016 | Option Exercise | $18.00 | 14,687 | 264,366 | 517,683 | Dec 07, 2016, 04:40 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Rosiello Robert L. | EVP, Corp Dev & Strategy | Nov 04, 2016 | Option Exercise | $22.06 | 817 | 18,023 | 532,370 | Nov 08, 2016, 04:41 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Rosiello Robert L. | EVP, Chief Financial Officer | Aug 03, 2016 | Option Exercise | $23.54 | 1,338 | 31,497 | 533,187 | Aug 05, 2016, 04:44 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Rosiello Robert L. | EVP, Chief Financial Officer | Jul 31, 2015 | Buy | $257.25 | 704 | 181,104 | 441,675 | Aug 03, 2015, 04:54 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Rosiello Robert L. | EVP, Chief Financial Officer | Jul 30, 2015 | Buy | $253.99 | 7,171 | 1,821,362 | 440,971 | Aug 03, 2015, 04:54 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Rosiello Robert L. | Executive Vice President | Jun 12, 2015 | Buy | $232.51 | 12,900 | 2,999,379 | 12,900 | Jun 16, 2015, 04:01 PM |
Menu